The Stem Cell Network (SCN) announced funding of $9 million for innovative stem cell and regenerative medicine research that will help translate discoveries into better health and economic growth for Canadians.
You are here
Coverage of the latest news and updates from ongoing clinical trials from various sources.
Cell reprogramming does not happen exactly as we thought. A team from the Spanish National Cancer Research Centre (CNIO), Madrid, has shown that tissue damage is a relevant factor for cells to go back to an embryonic state.
Researchers have developed a gel for growing miniaturized body organs that can be used in clinical diagnostics and drug development. Organoids are miniature organs that can be grown in the lab from a person's stem cells.
Among several studies on brain cancer released in November was one focusing on children diagnosed with the brain tumor malignant glioma, a condition that often has a very poor prognosis.
Glioblastoma multiforme remains the most common and highly lethal brain cancer and is known for its ability to relapse.
Researchers at the University of Michigan have transplanted lab-grown mini lungs into immunosuppressed mice where the structures were able to survive, grow and mature.
The California Institute of Regenerative Medicine (CIRM) has issued a call for applications for two new rounds of funding for stem cell research.
Scientists have identified two chemicals that improve their ability to transform scar tissue in a heart into healthy, beating heart muscle. The new discovery advances efforts to find new and effective treatments for heart failure.
New research explains how metastatic breast cancer cells might use bone marrow-derived mesenchymal stem cells (MSCs) to help them spread to bone tissue.
The prognosis for patients diagnosed with scleroderma, an autoimmune disease characterized by fibrosis of the skin, is not typically a rosy one. With limited treatment options available, those suffering from the disorder can face disabling hardening and tightening of their skin.